| http://dbpedia.org/ontology/abstract
|
Prescient Therapeutics Ltd is a clinical s … Prescient Therapeutics Ltd is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cellular therapies. The company's key programs are focused on the development of a universal CAR-T platform (OmniCAR), enhanced CAR-T cell manufacturing & function (CellPryme) and on two small molecule drug targeted therapies (PTX-100 & PTX-200).argeted therapies (PTX-100 & PTX-200).
|
| http://dbpedia.org/ontology/foundingYear
|
2014
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Australia +
, http://dbpedia.org/resource/Melbourne +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-gen-cell-therapeutics/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
48742105
|
| http://dbpedia.org/ontology/wikiPageLength
|
19149
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1114984827
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Australian_Securities_Exchange +
, http://dbpedia.org/resource/Gastric_cancer +
, http://dbpedia.org/resource/Acute_myeloid_leukemia +
, http://dbpedia.org/resource/Mevalonate_pathway +
, http://dbpedia.org/resource/Neoadjuvant_therapy +
, http://dbpedia.org/resource/Immune_receptor +
, http://dbpedia.org/resource/Regulatory_T_cell +
, http://dbpedia.org/resource/Allogeneic +
, http://dbpedia.org/resource/Reverse_takeover +
, http://dbpedia.org/resource/Cell_therapy +
, http://dbpedia.org/resource/Tumor_microenvironment +
, http://dbpedia.org/resource/Andrew_D._Hamilton +
, http://dbpedia.org/resource/University_of_Oxford +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Australian_Securities_Exchange +
, http://dbpedia.org/resource/Category:Science_and_technology_in_Melbourne +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Glioblastoma +
, http://dbpedia.org/resource/Aptamer +
, http://dbpedia.org/resource/Australia +
, http://dbpedia.org/resource/Rho_family_of_GTPases +
, http://dbpedia.org/resource/Immunogenicity +
, http://dbpedia.org/resource/Lipid +
, http://dbpedia.org/resource/T-cell_receptor +
, http://dbpedia.org/resource/HER2/neu +
, http://dbpedia.org/resource/Peter_MacCallum_Cancer_Centre +
, http://dbpedia.org/resource/AKT +
, http://dbpedia.org/resource/MD_Anderson_Cancer_Center +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Acute_Myeloid_Leukemia +
, http://dbpedia.org/resource/Orphan_drug_designation +
, http://dbpedia.org/resource/Covalent_bond +
, http://dbpedia.org/resource/Adjuvant_therapy +
, http://dbpedia.org/resource/Macrophage +
, http://dbpedia.org/resource/GTPase +
, http://dbpedia.org/resource/Neoplasm +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Australia +
, http://dbpedia.org/resource/Paul_A._Hopper +
, http://dbpedia.org/resource/Autologous +
, http://dbpedia.org/resource/Geranylgeranyltransferase_type_1 +
, http://dbpedia.org/resource/Ovarian_cancer +
, http://dbpedia.org/resource/Breast_cancer +
, http://dbpedia.org/resource/Natural_killer_cell +
, http://dbpedia.org/resource/HIV +
, http://dbpedia.org/resource/Category:Cancer_organizations_based_in_the_United_States +
, http://dbpedia.org/resource/Triciribine +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/Said_Sebti +
, http://dbpedia.org/resource/Chimeric_antigen_receptor_T_cell +
, http://dbpedia.org/resource/Single-chain_variable_fragment +
, http://dbpedia.org/resource/Melbourne +
, http://dbpedia.org/resource/Yale_University +
, http://dbpedia.org/resource/University_of_Pennsylvania +
, http://dbpedia.org/resource/Apoptosis +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Small-molecule_drug +
, http://dbpedia.org/resource/Tampa%2C_Florida +
, http://dbpedia.org/resource/H._Lee_Moffitt_Cancer_Center_&_Research_Institute +
|
| http://dbpedia.org/property/foundation
|
2014
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Dan Shelly
, Steven Yatomi-Clarke
, Steve Engle
, Rebecca Lim
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Melbourne +
, http://dbpedia.org/resource/Australia +
|
| http://dbpedia.org/property/name
|
Prescient Therapeutics Ltd
|
| http://dbpedia.org/property/products
|
OmniCAR, CellPryme, PTX-200, PTX-100
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Asx +
, http://dbpedia.org/resource/Template:Advert +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Cancer_organizations_based_in_the_United_States +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Australia +
, http://dbpedia.org/resource/Category:Science_and_technology_in_Melbourne +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Australian_Securities_Exchange +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Prescient_Therapeutics?oldid=1114984827&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Prescient_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
Prescient Therapeutics Ltd
|
| owl:sameAs |
http://www.wikidata.org/entity/Q25245415 +
, http://dbpedia.org/resource/Prescient_Therapeutics +
, https://global.dbpedia.org/id/2Ng1V +
, http://yago-knowledge.org/resource/Prescient_Therapeutics +
|
| rdf:type |
http://schema.org/Organization +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
Prescient Therapeutics Ltd is a clinical s … Prescient Therapeutics Ltd is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cellular therapies. The company's key programs are focused on the development of a universal CAR-T platform (OmniCAR), enhanced CAR-T cell manufacturing & function (CellPryme) and on two small molecule drug targeted therapies (PTX-100 & PTX-200).argeted therapies (PTX-100 & PTX-200).
|
| rdfs:label |
Prescient Therapeutics
|
